Form D/A

View Original Filing

Notice of Exempt Offering of Securities

Item 1. Issuer's Identity

Name of Issuer:
ALLIQUA, INC.
Jurisdiction of Incorporation/Organization
FL
Year of Incorporation/Organization
Over Five Years Ago

Previous Name(s)

  • HEPALIFE TECHNOLOGIES INC
  • ZETA CORP
  • ZETA CORP /CA
Entity Type
CORPORATION

Item 2 Issuer Principal Place of Business and Contact Information

850 THIRD AVENUE
SUITE 1801
NEW YORK, NY 10022
Phone Number: subscription required

Item 3. Related Persons

Name
RICHARD ROSENBLUM
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
DAVID STEFANSKY
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
JEROME ZELDIS
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
JOSEPH LEONE
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
KENNETH LONDONER
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
KENNETH PEARSEN
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
JEFFREY SKLAR
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
STEVEN BERGER
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
Clarification of Response
CHIEF FINANCIAL OFFICER OF THE ISSUER

Item 3. Related Persons

Name
DAVID JOHNSON
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
  • DIRECTOR
Clarification of Response
PRESIDENT, CHIEF EXECUTIVE OFFICER AND DIRECTOR OF THE ISSUER

Item 4. Industry Group

BIOTECHNOLOGY

Item 5. Issuer Size

Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE

Item 6. Federal Exemptions and Exclusions Claimed

Item 7. Type of Filing

Amendment
Date of First Sale in this Offering:
04/11/2013

Item 8. Duration of Offering

Does the issuer intend this offering to last more than one year?
No

Item 9. Type(s) of Securities Offered

  • Equity
  • Option, Warrant or Other Right to Acquire Another Security

Item 10. Business Combination Transaction

Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response

Item 11. Minimum Investment

Minimum Investment accepted from any outside investor
0

Item 12. Sales Compensation

Recipient
LAIDLAW COMPANY (UK) LTD.
Recipient CRD Number
119037
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
546 5TH AVENUE
5TH FLOOR
NEW YORK, NY 10036
States of Solicitation
  • AR
  • CA
  • FL
  • IA
  • NJ
  • NC
  • OK
  • PA
  • TX

Item 13. Offering and Sales Amounts

Total Offering Amount
3000000
Total Amount Sold
812000
Total Remaining to be Sold
2188000
Clarification of Response

Item 14. Investors

Securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
19

Item 15. Sales Commissions and Finders' Fees Expenses

Sales Commissions:
70200.0
Finders' Fees
0.0
Clarification of Response
THE ISSUER ALSO ISSUED A FIVE YEAR WARRANT TO PURCHASE 866,667 SHARES OF COMMON STOCK AT AN EXERCISE PRICE OF $0.097 PER SHARE TO THE PLACEMENT AGENT AS CONSIDERATION FOR SERVING AS THE PLACEMENT AGENT.

Item 16. Use of Proceeds

Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers,directors or promoters in response to Item 3 above.
0.0
Clarification of Response

Signature and Submission

Issuer Name
ALLIQUA, INC.
Issuer Signature
STEVEN BERGER
Signer Name
STEVEN BERGER
Signer Title
CHIEF FINANCIAL OFFICER
Signature Date
05/07/2013
WhaleWisdom Logo

Elevate your investments